You are now leaving www.kedrion.at. Medical information including licensed uses may be different outside of the EU countries.
NO
YES

HIGHLIGHTS

News Highlight Thumbnail - Kedrion Biopharma joins IPOPI in supporting patients with APP PID Genius

EVENTS

Kedrion Biopharma joins IPOPI in supporting patients with APP PID Genius

This new APP, presented at the IPIC Congress in Dubai, will be the personal assistant to people living with PIDs

read more 
News Highlight Thumbnail -  Kedrion Biopharma strengthens its presence in Russia

CORPORATE

Kedrion Biopharma strengthens its presence in Russia

Memorandum of Understanding with Russian pharmaceutical companies for a joint plasma products manufacturing program

read more 

CORPORATE

IVIg efficacy in chronic inflammatory polyradiculoneuropathy (CIDP)

Continuous support by Kedrion Biopharma to research and partnering patient associations

read more 
  1. PLASMA & BIOTHERAPIES - 15-12-2014

    Kedrion announces new registrations for its Anti-D products

    Such new registrations are steps forward in the process to help reduce HDN risk all over the world

    read more 
  2. CORPORATE - 14-11-2014

    Kedrion International opens a new representative office in Warsaw

    The potential growth of the plasma-derivatives market in Poland was a key factor for this choice

    read more 
  3. PLASMA & BIOTHERAPIES - 24-06-2014

    Counterfeit RhoGAM Ultra-Filtered PLUS used for preventing HDN found in India

    Johnson & Johnson Limited has identified counterfeit RhoGAM Ultra-Filtered PLUS in the state of West Bengal and Uttar Pradesh in India. This issue does not involve any other product manufactured or distributed by Ortho Clinical Diagnostics or Kedrion Biopharma India Pvt. Ltd.

    read more 
  4. CORPORATE - 20-05-2014

    Kedrion, one of Italy’s most innovative companies in 2014

    The MIT Technology Review Italia’s award given in Bologna in mid-May

    read more 

Pages

For more information please contact: pressoffice@kedrion.com